FCX
63
-4
NTRS
57
-2
WDC
50
-2
DNB
84
16
PAYX
60
3
HPE
70
17
HD
54
5
TSN
42
4
WMT
63
3
ORCL
71
2
DD
60
-7
SO
57
7
SYY
49
2
NKE
30
2
ICE
59
2
SE
50
-5
FOXA
66
2
AVGO
42
-2
CFG
68
-2
K
59
6
FCX
63
-4
NTRS
57
-2
WDC
50
-2
DNB
84
16
PAYX
60
3
HPE
70
17
HD
54
5
TSN
42
4
WMT
63
3
ORCL
71
2
DD
60
-7
SO
57
7
SYY
49
2
NKE
30
2
ICE
59
2
SE
50
-5
FOXA
66
2
AVGO
42
-2
CFG
68
-2
K
59
6
Financhill
Back

Alaunos Therapeutics 10K Form

Sell
20

TCRT
Alaunos Therapeutics

Last Price:
2.00
Seasonality Move:
11.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TCRT News And Ratings

See the #1 stock for the next 7 days that we like better than TCRT

TCRT Financial Statistics

Sales & Book Value

Annual Sales: $5K
Cash Flow: $-1.68M
Price / Cash Flow: 0
Annual Sales: $2.36
Price / Book: 0.84

Profitability

EPS (TTM): -12.70800
Net Income (TTM): $-19.13M
Gross Margin: $0
Return on Equity: -189.69%
Return on Assets: -144.17%

Alaunos Therapeutics Earnings Forecast

Key Alaunos Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for TCRT have been equal to 244,380.00% of Gross Profit Margin.
  • The Research & Development expenses have been 325,580.00% of Revenue.
  • The Interest Expense is -5.47% of Operating Income.
  • The Net Earning history of TCRT is -702,800.00% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

Alaunos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TCRT
Website: alaunos.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.16
Quick Ratio: 2.72

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TCRT Technical Analysis vs Fundamental Analysis

Sell
20
Alaunos Therapeutics (TCRT) is a Sell

Is Alaunos Therapeutics a Buy or a Sell?